ConductScience.org, home

Gene · 406901

Papers3,765

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Complex interactions between miR-107 and PTEN gene expression, more specifically in viral and NASH cirrhosis.Biochem Biophys Rep202642699728PubTator, text miningPubMed
MicroRNA profiling of filtering and non-filtering regions of human trabecular meshwork: changes with ageing and in glaucoma.Mol Biol Rep202642663796PubTator, text miningPubMed
Plasma-derived extracellular vesicle microRNA as a potential biomarker associated with disease progression in non-severe dengue infection.Infection202642627622PubTator, text miningPubMed
Association of target miRNAs expression in blood plasma and cerebrospinal fluid with Alzheimer's disease biomarkers level and cognitive decline.Sci Rep202642481587PubTator, text miningPubMed
Neuroinflammation- molecular target based therapeutic approach.Adv Protein Chem Struct Biol202642448410PubTator, text miningPubMed
Retraction: miR-107 inhibited malignant biological behavior of non-small cell lung cancer cells by regulating the STK33/ERK signaling pathway in vivo and vitro.J Thorac Dis202642444893PubTator, text miningPubMed
Circulating miR-107, miR-199, and miR-485 Have High Diagnostic Potential in Non-small Cell Lung Cancer: An Exploratory Study.Clin Med Insights Oncol202642403938PubTator, text miningPubMed
Establishment of an Acid-Induced Het-1A Cell Model and Functional Analysis of the miR-107/FGFRL1 Axis.J Vis Exp202642296079PubTator, text miningPubMed
The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR.Cancer Gene Ther202642230820PubTator, text miningPubMed
Identification of miR-107 and miR-451-a as Prognostic Biomarkers in Acute Myeloid Leukemia.Hematol Oncol202642223153PubTator, text miningPubMed
Retraction notice to "microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes" [Urologic Oncology: Seminars and Original Investigations 33 (2015) 205.e1-205.e11].
Urol Oncol202642190591PubTator, text miningPubMed
Dexmedetomidine mitigates postoperative delirium after hip fracture surgery in elderly patients by modulating miR-107 expression.J Orthop Surg Res202642129851PubTator, text miningPubMed
Night shift work and epigenetic modifications: cardiovascular-related miRNA expression within a European cohort of night shift workers.Environ Health202642129779PubTator, text miningPubMed
Peripheral blood E2F1 expression and clinical significance in asthma with persistent airflow obstruction.Int Immunopharmacol202642066552PubTator, text miningPubMed
NEAT1 as a Diagnostic Biomarker and Therapeutic Target for Alzheimer's Disease: A Comprehensive Review.CNS Neurol Disord Drug Targets202641930583PubTator, text miningPubMed
Cationic lipid-based nanoparticles for therapeutic delivery in cancer treatment: physicochemical characteristics, therapeutic cargos, and clinical potential.Appl Microsc202641922813PubTator, text miningPubMed
Decoding microRNA-Protein Interaction Networks in Alzheimer's Disease: Molecular Mechanisms and Clinical Implications.Curr Alzheimer Res202641918207PubTator, text miningPubMed
Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents.Brain Sci202641892626PubTator, text miningPubMed
Retraction Notice to: circFGFR4 Promotes Differentiation of Myoblasts via Binding miR-107 to Relieve Its Inhibition of Wnt3a.Mol Ther Nucleic Acids202641810138PubTator, text miningPubMed
Diagnostic potential of circular RNAs in carotid atherosclerotic plaque vulnerability.Noncoding RNA Res202641809636PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/406901/papers